Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neuroendocrine carcinoma of prostate
ADR ID BADD_A10509
ADR Hierarchy
05      Endocrine disorders
05.08      Neoplastic and ectopic endocrinopathies
05.08.01      Endocrine neoplasms NEC
05.08.01.020      Neuroendocrine carcinoma of prostate
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.25      Reproductive neoplasms male malignant and unspecified
16.25.01      Prostatic neoplasms malignant
16.25.01.009      Neuroendocrine carcinoma of prostate
21      Reproductive system and breast disorders
21.04      Prostatic disorders (excl infections and inflammations)
21.04.02      Prostatic neoplasms and hypertrophy
21.04.02.013      Neuroendocrine carcinoma of prostate
Description Not Available
MedDRA Code 10082915
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neuroendocrine carcinoma of prostate
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00271Bicalutamide0.001406%
BADD_D00775Enzalutamide0.000334%
BADD_D01260Leuprolide acetate0.002151%
The 1th Page    1    Total 1 Pages